GFI vs. RIGL
GFI (Gold Fields Limited) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. GFI operates in Gold (Basic Materials), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, GFI returned 20.74%/yr vs 3.86%/yr for RIGL. Their 0.07 correlation means their historical movements had little consistent relationship.
Performance
GFI vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GFI achieves a -23.58% return, which is significantly lower than RIGL's -14.06% return. Over the past 10 years, GFI has outperformed RIGL with an annualized return of 20.74%, while RIGL has yielded a comparatively lower 3.86% annualized return.
GFI
- 1D
- -3.31%
- 1M
- -3.88%
- 6M
- -33.43%
- YTD
- -23.58%
- 1Y
- 38.42%
- 3Y*
- 37.99%
- 5Y*
- 31.37%
- 10Y*
- 20.74%
- ALL TIME*
- 6.40%
RIGL
- 1D
- -3.28%
- 1M
- -3.87%
- 6M
- 5.59%
- YTD
- -14.06%
- 1Y
- 74.79%
- 3Y*
- 40.40%
- 5Y*
- -1.65%
- 10Y*
- 3.86%
- ALL TIME*
- -10.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $102.92M | $118.13M | $131.61M | |
| $11.43M | $14.01M | $13.32M |
GFI vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GFI Gold Fields Limited | -23.58% | 240.42% | -6.27% | 44.90% | -2.61% | 23.33% | 43.02% | 89.47% | -16.75% | 45.29% |
RIGL Rigel Pharmaceuticals, Inc. | -14.06% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between GFI and RIGL is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.07 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.04 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.02 |
Correlation (All Time) Calculated using the full available price history since Aug 24, 2007 | 0.07 |
Fundamentals
GFI:
$29.02B
RIGL:
$681.06M
GFI:
$5.39
RIGL:
$18.94
GFI:
6.01
RIGL:
1.94
GFI:
0.10
RIGL:
0.00
GFI:
2.07
RIGL:
2.36
GFI:
3.44
RIGL:
1.81
GFI:
$13.98B
RIGL:
$299.77M
GFI:
$7.34B
RIGL:
$279.95M
GFI:
$8.04B
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GFI vs. RIGL — Risk / Return Rank
GFI
RIGL
GFI vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Gold Fields Limited (GFI) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GFI | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.45 | ||
| Sortino ratioReturn per unit of downside risk | -0.77 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.25 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.81 | 1.50 | -0.69 |
| Martin ratioReturn relative to average drawdown | 1.70 | 2.51 | -0.82 |
Loading charts...
Drawdowns
GFI vs. RIGL - Drawdown Comparison
The maximum GFI drawdown since its inception was -88.05%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for GFI and RIGL.
Loading charts...
Drawdown Indicators
| GFI | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.05% | -99.37% | +11.32% |
Max Drawdown (1Y)Largest decline over 1 year | -47.72% | -50.08% | +2.36% |
Max Drawdown (3Y)Largest decline over 3 years | -47.72% | -50.76% | +3.04% |
Max Drawdown (5Y)Largest decline over 5 years | -56.22% | -83.85% | +27.63% |
Max Drawdown (10Y)Largest decline over 10 years | -63.09% | -86.40% | +23.31% |
Current DrawdownCurrent decline from peak | -45.76% | -96.55% | +50.79% |
Average DrawdownAverage peak-to-trough decline | -44.24% | -90.93% | +46.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.70% | 29.86% | -7.16% |
Volatility
GFI vs. RIGL - Volatility Comparison
Gold Fields Limited (GFI) and Rigel Pharmaceuticals, Inc. (RIGL) have volatilities of 12.44% and 11.97%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GFI | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.44% | 11.97% | +0.47% |
Volatility (6M)Calculated over the trailing 6-month period | 46.19% | 34.77% | +11.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.58% | 70.02% | -8.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.84% | 85.52% | -32.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.58% | 82.76% | -28.18% |
Dividends
GFI vs. RIGL - Dividend Comparison
GFI's dividend yield for the trailing twelve months is around 5.68%, while RIGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GFI Gold Fields Limited | 5.68% | 1.77% | 2.94% | 2.87% | 3.40% | 3.24% | 1.72% | 0.81% | 1.61% | 1.41% | 1.35% | 0.60% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
GFI vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Gold Fields Limited and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GFI vs. RIGL - Profitability Comparison
GFI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Gold Fields Limited reported a gross profit of 3.00B and revenue of 5.29B. Therefore, the gross margin over that period was 56.7%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
GFI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Gold Fields Limited reported an operating income of 2.71B and revenue of 5.29B, resulting in an operating margin of 51.3%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
GFI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Gold Fields Limited reported a net income of 2.55B and revenue of 5.29B, resulting in a net margin of 48.2%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
GFI and RIGL have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GFI has higher volatility (12.44%) compared to RIGL (11.97%). In terms of maximum drawdown, GFI dropped -88.05% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (1.07 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GFI and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer